Heron Therapeutics HRTX 深 沪
已收盘 08-01 16:00:00 美东时间
1.69
-0.040
-2.31%
华盛通- 最 高1.735
- 今 开1.73
- 成交量 101.77万股
- 最 低 1.655
- 昨 收 1.73
- 总市值 2.59亿
- 52周最高 2.68
- 市盈率 静 --
- 换手率 0.67%
- 52周最低 1.04
- 委 比 -43.87%
- 总股本 1.53亿
- 历史最高 42.90
- 量 比 1.21
- 振 幅 4.62%
- 历史最低 0.16
- 每 手 1
- 风险率 0.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HeartCore Announces Strategic Financing to Support Software Business Growth Initiatives
HeartCore Enterprises, Inc. (NASDAQ: HTCR) has entered into agreements with Crom Structured Opportunities Fund I, LP, allowing HeartCore to raise up to $27 million in total proceeds to support its M&A strategy and meet Nasdaq listing requirements. The company, based in Tokyo, specializes in enterprise software, data consulting, and digital transformation.
07-01 12:30
Heartland Express, Inc. Declares Regular Quarterly Dividend
Heartland Express, Inc.宣布了 quarterly cash dividend 的发放，每股0.02美元，将于7月3日支付，股东记录截止到6月23日。预计支付总金额约为160万美元，基于7800万股流通股。这是公司连续88次发放季度股息，累计支付5.583亿美元，包括4次特别股息。前瞻性声明基于当前信息，实际结果可能有差异，公司无义务更新声明。媒体联系人有Michael J. Gerdin和Christopher A. Strain，电话319-645-7060。
06-13 19:00
美股大行评级 | eToro Group获多家大行首予买入评级，甲骨文获多家机构上调目标价
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139116149842006017.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持PolyPid(PYPD)"买入"评级，目标价从11美元升至13美元</p> <p>• HC Wainwright & Co.：维持Vertical Aerosp
06-10 09:45
HC Wainwright & Co. Initiates Coverage On Heron Therapeutics with Buy Rating, Announces Price Target of $6
HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Heron Therapeutics (NASDAQ:HRTX) with a Buy rating and announces Price Target of $6.
06-09 19:29
Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations
— Company Grants Mylan a License to Market Generic CINVANTI® and APONVIE® Beginning in June 2032 — CARY, N.C., May 6, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or...
05-06 19:30
Here are the major earnings before the open tomorrow
Major earnings expected before the bell on Tuesday include: Archer-Daniels-Midland (ADM) Datadog (DDOG) Duke Energy (DUK) Marathon Petroleum (MPC) MPLX (MPLX) Other earnings slated for release before ...
05-06 06:00
Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025
CARY, N.C., April 22, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will...
04-23 04:05
美股大行评级 | 潜在涨幅223.78%！内克塔治疗获杰富瑞升目标价至2美元，上调至"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117736711687032832.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 杰富瑞：上调内克塔治疗(NKTR)评级至"买入"，目标价从1美元升至2美元</p> <p>• Roth MKM：维持Lovesac Co.(LOVE)"买入"评级，目标价从22美元升至28美元</p> <p>• Macq
04-14 07:05
Needham Keeps Their Buy Rating on Heron Therapeutics (HRTX)
In a report released today, Serge Belanger from Needham maintained a Buy rating...
04-11 18:40
美股牛股 | 暴涨102%！Organogenesis Q4业绩超预期；SoundHound AI隔夜涨超17%，Q4营收暴增101%
暴涨102%！Organogenesis Q4业绩超预期；SoundHound AI隔夜涨超17%，Q4营收暴增101%>>
03-01 13:34
